Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Brian H. Kushner(Memorial Sloan Kettering Cancer Center), N K Cheung(Memorial Sloan Kettering Cancer Center), Michael P. LaQuaglia(Memorial Sloan Kettering Cancer Center), R.J. O’Reilly, Subhash C. Gulati, Lynda R. Mandell(Roswell Park Comprehensive Cancer Center)
Cited by 95
Related Papers
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
|Nature Communications|2022|219